Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World October 23, 2009 Matt Wilkinson	What's in a pill? Buying cheap drugs over the internet is well known to be a risky business. But the sinister menace of the 'falsified' active pharmaceutical ingredient gets far less publicity.
Chemistry World November 23, 2009 Phil Taylor	Pharma group aims to banish contaminated ingredients An international consortium aiming to tighten security in the pharmaceutical supply chain and avoid contaminated ingredients finding their way into medicines had its European debut this month.
Chemistry World May 23, 2012 Andy Extance	Drug watchdogs mark out global territory The US Food and Drug Administration has published plans to ensure that American citizens continue to enjoy access to safe drugs, even as the regulatory pressures of globalization grow.
Pharmaceutical Executive September 1, 2008	How Do You Solve a Problem Like Manufacturing? Outsourcing saves pharmaceutical companies money -- except when it doesn't. Here's how to decide what to do.
Pharmaceutical Executive March 1, 2006 Sarah Houlton	Global Report: Chemicals Legislation in Europe Chemicals legislation in Europe may affect pharma's relationship with suppliers.
Pharmaceutical Executive September 1, 2008 Jill Wechsler	Foreign Affairs FDA missteps and global outsourcing are drawing Congressional scrutiny and prompting new oversight approaches.
Food Processing February 2008	Ingredients from Where? A flattening world, consumer price resistance and overtaxed regulators require new approaches to ensure the safety of imported food ingredients.
The Motley Fool February 21, 2008 Brian Lawler	A Bit of Irony From the FDA The agency has a mixed message on drug importation, as evidenced in the recent possible contamination of China-produced Heparin.
Pharmaceutical Executive April 1, 2006 Ron Feemster	Thought Leader: Q&A with Joel A. Tune Pharma still enlists contract manufacturers as safety valves, but today's drug developers have also begun to outsource the production of increasingly complicated compounds while they are still in clinical trials.
Pharmaceutical Executive November 1, 2006 Sarah Houlton	Global Report: 'Bout Time The European Union has been late to enter the fight against counterfeiting. Fed up, Parliament has passed a proposal designed to give its countries the nudge they need.
Entrepreneur September 2007 Chris Penttila	Keep It Clean With the recent rash of tainted imports, how can you be sure your goods are safe? Being vigilant is your best antidote.
Pharmaceutical Executive November 1, 2011 Jill Wechsler	The Drug Shortages Struggle Clamor for critical therapies prompts probes of prices, production practices.
Chemistry World October 23, 2013 Sarah Houlton	Pharma manufacturing woes dog industry Many problems arise from quality control failures, according to Nicholson Price from Harvard Law School's Petrie-Flom center for health law policy, biotechnology and bioethics, this is not the only problem -- regulatory constraints can prevent process improvements being made.
Pharmaceutical Executive August 1, 2008	Harbingers of Change The pharmaceutical industry is changing. Here are eight seminal events that describe how.
Pharmaceutical Executive December 1, 2005 Jill Wechsler	Washington Report: Big Production Drug manufacturing costs too much and is cumbersome to regulate. FDA's answer: Quality by design, which shifts the emphasis from testing the final product to building quality into the manufacturing process from the beginning.
Chemistry World July 10, 2012	Interview: EMA head Guido Rasi His five-year appointment comes during a period of dramatic change for the pharma industry, which is struggling with patent expirations for many of its biggest selling drugs and a paucity of new drugs coming through the pipeline to take their place.
BusinessWeek March 31, 2011 David Voreacos et al.	Johnson & Johnson's Quality Catastrophe After 50-plus product recalls in 15 months, the $60 billion company is fighting to clear its once-trusted name.
The Motley Fool April 2, 2008 Brian Lawler	Medicines Company Sets Itself Apart Drugmaker Medicines Company wants to distance its angioplasty treatment from heparin.
Chemistry World December 19, 2013 Steven Ford	Cut price pills cost more than pennies We need to take a good look at supply diversity: we cannot allow the situation where suppliers are too big to fail. It's time to raise the bar across the pharmaceutical supply line from producer to patient.
Pharmaceutical Executive April 1, 2011	The Big Business of Boosting Performance Dutch-based DSM N.V. is seeking innovative ways to partner through bolstering manufacturing.
Food Engineering September 3, 2007 Jim Getchell	Globalization: Where in the World is Your Supply Chain? Globalization and outsourcing offer opportunities and risks for US food manufacturers striving to optimize their supply chains.
Food Engineering March 1, 2009 Wayne Labs	Food Safety at the Crossroads The recent peanut paste recall -- largest ever in terms of supply chain -- points to the urgency of food safety today.
Food Processing October 2008 Dave Fusaro	Supply Chain Pains Who's managing whom? In a year of unprecedented pressures, our exclusive joint survey finds a tug of war between food processors and their suppliers.
Pharmaceutical Executive September 1, 2014 William Looney	Ireland's Celtic Tiger: Back on the Hunt Leaders from industry, government, and the CRO community examine Ireland's future as a magnet for life science investments, and what the nation must do to remain the leading exporter of finished pharmaceutical products.
Chemistry World December 22, 2011 Sarah Houlton	Pharma braces for patent cliff impact It remains to be seen quite how far Lipitor sales will fall. Ranbaxy has six months of exclusivity for generic competition.
Pharmaceutical Executive July 1, 2013 Wernli & Ganor	Dangerous Liaisons: Terrorism and Pharma How vulnerable is Big Pharma to the predations of organized terrorist groups or that rogue malcontent with an agenda to wreak havoc on society?
Pharmaceutical Executive January 1, 2009 Jill Wechsler	FDA Turnaround Time Will more resources and new leadership fix FDA, or is a major overhaul in order?
Pharmaceutical Executive January 1, 2012 Jill Wechsler	New Year, New Issues Look for action in 2012 on drug access, shortages, innovation, and transparency. The 800-pound gorilla in the room is the looming Supreme Court decision on the constitutionality of the Obama health reform legislation.
Chemistry World December 15, 2009 Sarah Houlton	Pharma's year of merger mania Away from the corporate world, the big pharma story of 2009 was the emergence of a new health scare - swine flu.
Food Engineering January 1, 2008	Tech Update: Process Control Advanced control solutions enable processors to satisfy regulatory demands while gaining a competitive edge.
IndustryWeek November 1, 2008 Nick Zubko	The Secret Ingredients in Food Safety As contaminations continue to make headlines, manufacturers are under constant scrutiny to keep our food safe. But as globalization continues and consumer demands change, their job is only getting tougher.
Pharmaceutical Executive January 1, 2014 Jill Wechsler	Pharma Challenges for 2014 Pricing and personalized medicine are key themes shaping drug development and marketing
Chemistry World November 2, 2011 Rebecca Trager	Escalating Drug Dearth Spooks White House Manufacturing problems are the principal reason for the rapid growth in drug shortages.
Pharmaceutical Executive July 1, 2013 Jill Wechsler	Seeking Supply Chain Security FDA wants pharma leaders to do more to ensure drug quality at home and abroad.
Pharmaceutical Executive January 1, 2007 Jill Wechsler	Washington Report: A Full Plate It's going to be a busy year in Washington for the pharmaceutical industry. Drug safety, unapproved uses, e-data requirements, and a shift to personalized medicine are just a few of the hot issues on tap for 2007.
BusinessWeek May 21, 2007 John Carey	How Safe Is The Food Supply? The hamstrung FDA may be unable to prevent a contamination crisis.
Pharmaceutical Executive January 1, 2011	The Steep, Slow Climb A survey of leading experts reveals 2011's sobering reality and the trends that smart drugmakers will follow into the next decade.
The Motley Fool June 1, 2005 Rich Duprey	Able Labs Disabled The generic drug maker recalls its entire inventory over quality concerns. Its stock price cratered 75% the day after the announcement and has since fallen another 30% since then.
The Motley Fool July 5, 2006 Rich Duprey	Flu Vaccine Deja Vu The country's largest vaccine maker, Sanofi Aventis, gets an FDA warning letter reminiscent of the 2004 debacle.
Bio-IT World July 15, 2003	Solutia Streamlines Route from Lab to Production Solutia Pharmaceutical Services, under pressure to control costs, built a single, integrated software application that enables management and control of every resource used in the development and manufacture of API (active pharmaceutical ingredient) products.
Food Processing January 2006 Kantha Shelke	Ingredient forensics It's like CSI: New scientific techniques can uncover the source of pathogens, contamination, even genetic modification in foods and their ingredients.
Pharmaceutical Executive August 1, 2006 Patrick Clinton	From the Editor: Take Your Seat There's a lot to accomplish in the pharmaceutical industry. But considering what the industry has done in 25 years, it's not impossible.
Chemistry World February 15, 2008 James Mitchell Crow	Industry Reports a Year of Mixed Fortune Despite the twin pressures of rising energy and feedstock prices, and a slowing economy in the US curbing demand, many companies in the chemical sectors have reported rising sales and profits in their financial reviews of 2007.
IndustryWeek March 1, 2007 David Blanchard	Manufacturing's Biggest Challenges -- IndustryWeek's 2007 Salary Survey Responses If you come to work everyday worrying about global competition, finding and keeping skilled labor, raw material shortages, and the quality of your product, you're not alone.
Food Processing October 2007	Regulatory Issues: FDA reports on allergen contamination If the food industry continues to show awareness of the dangers of food allergens, FDA and Congress likely will continue with a measured and deliberative approach.
Food Engineering May 1, 2005 John Blanchard	Beyond the Bioterrorism Act What you need to know about the final rule and additional initiatives to meet the intent of the Bioterrorism Act -- particularly Section 306, which relates directly to those who manufacture, process, pack, transport, distribute, receive, hold, or import food products.
Pharmaceutical Executive December 1, 2005 Patrick Clinton	PharmExec's 2006 Forecast The 2006 pharmaceutical industry is under assault from Congress, the press and the public, add a complex government program that will unimaginably change industry economics, and subtract revenues from off-patent products.
Pharmaceutical Executive January 1, 2007 Walter Armstrong	Forecast 2007: At Sea In times of crisis, it's harder than ever to take the long view. The healing arts may be as old as humankind, but the business of pharma is still in its infancy.
Chemistry World January 3, 2013 Sarah Houlton	2012 pharma industry roundup It may have been a relatively quiet year in terms of mergers and acquisitions, but the pharma industry nonetheless made plenty of headlines in 2012.
Pharmaceutical Executive March 1, 2009 Porth & Sillup	Fifth Annual Press Audit: Safety in the Spotlight Reporters pass on the typical litany of lightning-rod issues and instead devote more than three-quarters of all coverage in 2008 to drug safety and the regulators who enforce it.